Nanotechnology-Enhanced Vaccines for Respiratory Infections: Opportunities and Challenges
International Journal of Nanomedicine · 2026-06 · Volume 21 · 1-14
DOI: 10.2147/ijn.s612148 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026-06. Verfasst von Kaili Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nursing Department, Chun'an First People's Hospital, Hangzhou, Zhejiang, 311700, People's Republic of China. Hauptthemen laut MEDLINE: Respiratory Tract Infections, Nanotechnology, Vaccines. Die Arbeit nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
The continued global burden of the respiratory infections, despite availability of effective vaccines against major respiratory pathogens, represents the need to improve vaccination strategies. Although the conventional vaccines have shown effectiveness in many of the infectious diseases, they have serious limitations in developing the mucosal immunity and often fail to provide long-term protection against the rapidly mutating respiratory pathogens. In this area, nanotechnology offers novel solutions to enhance the potential of the respiratory vaccines. This review highlights recent advancements in the diverse nanotechnology platforms for respiratory vaccines, along with their transformative potentials, opportunities as well as challenges by covering the recent trends in the nanotechnology-based respiratory vaccines. Various nanotechnology platforms for respiratory vaccines include lipid nanoparticles (LNPs), polymeric nanoparticles, inorganic nanoparticles, biomimetic and self-assembling nanoplatforms. These platforms potentially address the key limitations of the traditional respiratory vaccines by improving the stability and targeted delivery of antigens, mucosal and cellular immune responses and flexible formulations against the evolving pathogens. However, challenges related to safety, scalability and real world applicability remain. The increasing research endeavors are gradually addressing the longstanding challenges and limitations of the nanotechnological measures in the respiratory vaccination and advancing this field with new opportunities for preventing the respiratory infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nursing Department, Chun'an First People's Hospital, Hangzhou, Zhejiang, 311700, People's Republic of China.
- School of Nursing, Shaoxing University, Shaoxing, 312000, People's Republic of China.
- Department of Respiratory Medicine, Chun'an First People's Hospital, Hangzhou, Zhejiang, 311700, People's Republic of China.
ORCID-Profile: Kaili Wang
Zitieren
APA
Wang, K., Jiang, Y., & Zhou, Y. (2026). Nanotechnology-Enhanced Vaccines for Respiratory Infections: Opportunities and Challenges. International Journal of Nanomedicine, Volume 21, 1-14. https://doi.org/10.2147/ijn.s612148
Vancouver
Wang K, Jiang Y, Zhou Y. Nanotechnology-Enhanced Vaccines for Respiratory Infections: Opportunities and Challenges. International Journal of Nanomedicine. 2026;Volume 21:1-14. doi:10.2147/ijn.s612148
BibTeX
@article{Wang2026,
author = {Wang, Kaili and Jiang, Yushan and Zhou, Yue},
title = {Nanotechnology-Enhanced Vaccines for Respiratory Infections: Opportunities and Challenges},
journal = {International Journal of Nanomedicine},
year = {2026},
volume = {Volume 21},
pages = {1--14},
doi = {10.2147/ijn.s612148}
}
EUVIMED